CHANGES IN INDICATORS OF THE LIPID PROFILE AND ADIPOKINES DEPENDING ON A1166C-GENE POLYMORPHISM OF ANGITENSIN II TYPE I AS A PREDICTOR OF THE DEVELOPMENT OF ARTERIAL HYPERTENSION

Authors

  • R. V. Hnizdiukh I. HORBACHEVSKY TERNOPIL NATIONAL UNIVERSITY
  • V. V. Shmanko I. HORBACHEVSKY TERNOPIL NATIONAL UNIVERSITY
  • L. M. Palytsya I. HORBACHEVSKY TERNOPIL NATIONAL UNIVERSITY

DOI:

https://doi.org/10.11603/mcch.2410-681X.2023.i4.14377

Keywords:

gene polymorphism, arterial hypertension, dyslipidemia

Abstract

Introduction. As evidenced by the results of research in recent years, genetic factors play an important role in the development and course of arterial hypertension. The study of the renin-angiotensin-aldosterone system gene polymorphism is a promising direction for assessing the relationship between heredity, arterial hypertension and dyslipidemia.

The aim of the study – to investigate the parameters of the lipid profile and adipokines depending on the polymorphism A1166C of the angiotensin II receptor type 1 gene as a predictor of the development of arterial hypertension.

Research Methods. 86 patients with arterial hypertension took part in the study. The control group consisted of 30 practically healthy people. Indicators of lipid metabolism in the blood serum of the studied patients were determined with the help of “Lachema” kits on the analyzer. The study of the allelic polymorphism A1166C of the angiotensin II receptor gene of the first type was carried out by the method of polymerase chain reaction with electrophoretic detection of the results.

Results and Discussion. The level of total cholesterol when replacing carriers of the CC genotype turned out to be significantly higher by 49.9 % compared to carriers of the AA genotype. The indicators of LDL and VLDL in carriers of the CC genotype were 1.4 and 3.2 times higher than in homozygotes for the A allele. The content of triglycerides in blood serum was significantly 2.48 times higher in carriers of the CC genotype than in patients with the AA genotype. HDL values ​​are lower in homozygotes for the C allele in patients with the AA genotype by 60.4 %. Carriers of the CC genotype are characterized by significantly higher levels of resistin, leptin, and adiponectin compared to carriers of the AA genotype, but the level of ghrelin is lower in carriers of the CC genotype.

Conclusions. The presence of the CC genotype of the angiotensin II type 1 receptor gene contributes to the development of dyslipidemia. In patients with arterial hypertension, the presence of the C allele of the angiotensin II type 1 gene contributes to a significant increase in serum adipokines and a decrease in the level of ghrelin.

References

Vedhasri Katari, L.N. Sai Priya Kanajam, Sreevalli Kokkiligadda, Tabitha Sharon & Padmalatha Kantamaneni (2023). A review on causes of myocardial infarction and its management. World Journal of Pharmaceutical Research, 12(6), 511-529. https://doi.org/10.20959/wjpr20236-27881

Gallagher, Michael D., & Alice S. Chen-Plotkin (2018). The post-GWAS era: from association to function. American Journal of Human Genetics, 102(5), 717-730. https://doi.org/10.1016/j.ajhg.2018.04.002 DOI: https://doi.org/10.1016/j.ajhg.2018.04.002

Baudin B. (2002). Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. Pharmacogenomics, 3(1), 65–73. https://doi.org/10.1517/14622416.3.1.65 DOI: https://doi.org/10.1517/14622416.3.1.65

Zeng, Y., Jiang, Y., Huang, Z., Li, K., & Zhou, Y. (2023). Association between AGTR1 (c.1166 A>C) Poly­morphisms and Kidney Injury in Hypertension. Frontiers in Bioscience (Landmark edition), 28 (7), 146. https://doi.org/10.31083/j.fbl2807146 DOI: https://doi.org/10.31083/j.fbl2807146

Zotova, T.Y., Kubanova, A.P., Azova, M.M., Aissa, A.A., Gigani, O.O., & Frolov, V.A. (2016). Analysis of polymorphism of angiotensin system genes (ACE, AGTR1, and AGT) and gene ITGB3 in patients with arterial hypertension in combination with metabolic syndrome. Bulletin of Experimental Biology and Medi­cine, 161(3), 334-338. https://doi.org/10.1007/s10517-016-3408-0 DOI: https://doi.org/10.1007/s10517-016-3408-0

Fan, R., Mao, S., Zhong, F., Gong, M., Yin, F., Hao, L., & Zhang, L. (2015). Association of AGTR1 promoter methylation levels with essential hypertension risk: A matched case-control study. Cytogenetic and genome research, 147 (2-3), 95-102. https://doi.org/10. 1159/000442366 DOI: https://doi.org/10.1159/000442366

Lin, J., Lin, S., Wu, Y., Wang, X., Wu, S., & Li, H. (2017). Hypomethylation of the angiotensin II type I receptor (AGTR1) gene along with environmental factors increases the risk for essential hypertension. Cardiology, 137(2), 126-135. https://doi.org/10.1159/000458520 DOI: https://doi.org/10.1159/000458520

Mohammad, R. Abdollahi, Rohan M. Lewis, Tom R. Gaunt, Debbie V.E. Cumming, Santiago Rodriguez, Matthew Rose-Zerilli, Andrew R., Collins, Holly, E. Syddall, William M. Howell, Cyrus Cooper, Keith, M. Godfrey, Iain, T. Cameron, Ian, N.M. Day. (2007). Quantitated transcript haplotypes (QTH) of AGTR1, reduced abundance of mRNA haplotypes containing 1166C (rs5186: A>C), and relevance to metabolic syndrome traits. Human Mutation, (28) 4, 365-373. https://doi.org/10.1002/humu.20454 DOI: https://doi.org/10.1002/humu.20454

Miyanaga, K., Fukuo, K., Akasaka, H., Katsuya, T., Fukada, R., Rakugi, H., & Kazumi, T. (2009). C allele of angiotensin II type 1 receptor gene A1166C polymorphism affects plasma adiponectin concentrations in healthy young Japanese women. Hypertension Research, 32(10), 901-905. https://doi.org/10.1038/hr.2009.111 DOI: https://doi.org/10.1038/hr.2009.111

Palatini, P., Ceolotto, G., Dorigatti, F., Mos, L., Santonastaso, M., Bratti, P., Papparella, I., Pessina, A.C., & Semplicini, A. (2009). Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. American Journal of Hyper­tension, 22(2), 208-214. https://doi.org/10.1038/ajh. 2008.319 DOI: https://doi.org/10.1038/ajh.2008.319

Xu, Y., Bao, Q., He, B., Pan, Y., Zhang, R., Mao, X., Tang, Z., Qu, L., Zhu, C., Tian, F., & Wang, S. (2012). Association of angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensin I converting enzyme 2 gene polymorphisms with the dyslipidemia in type 2 diabetic patients of Chinese Han origin. Journal of Endocrinological Investigation, 35(4), 378-383. https://doi.org/10.3275/7797

Demikhova, N.V. (2015). The state of pro-inflammatory factors of adipose tissue in arterial hypertension. Scientific Herald of Uzhhorod University. Seriia: Medy­tsyna, (1), 54-56 [in Ukrainian].

Mao, Y., Tokudome, T., & Kishimoto, I. (2016). Ghrelin and Blood Pressure Regulation. Current Hyper­tension Reports, 18(2), 15. https://doi.org/10.1007/s11906-015-0622-5 DOI: https://doi.org/10.1007/s11906-015-0622-5

Downloads

Published

2024-01-09

How to Cite

Hnizdiukh, R. V., Shmanko, V. V., & Palytsya, L. M. (2024). CHANGES IN INDICATORS OF THE LIPID PROFILE AND ADIPOKINES DEPENDING ON A1166C-GENE POLYMORPHISM OF ANGITENSIN II TYPE I AS A PREDICTOR OF THE DEVELOPMENT OF ARTERIAL HYPERTENSION. Medical and Clinical Chemistry, (4), 74–79. https://doi.org/10.11603/mcch.2410-681X.2023.i4.14377

Issue

No. 4 (2023)

Section

ORIGINAL INVESTIGATIONS

License

Copyright (c) 2024 Medical and Clinical Chemistry

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.